Nutritional and supranutritional levels of selenate differentially suppress prostate tumor growth in adult but not young nude mice

Journal of Nutritional Biochemistry

Volumn 23, Issue 9, 2012, Pages 1086-1091

  Holmstrom, Alexandra ^a   Wu, Ryan T Y ^a   Zeng, Huawei ^b   Lei, K Y ^a   Cheng, Wen Hsing ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Age; Nude mice; Prostate cancer; Selenium; Supranutrition; Xenograft

Indexed keywords

SELENATE; SELENIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PICHIA JADINII; PROSTATE CANCER; SELENIUM DEFICIENCY;

AGING; ANIMALS; ANTICARCINOGENIC AGENTS; CELL LINE, TUMOR; DIETARY SUPPLEMENTS; HUMANS; MALE; MICE; MICE, NUDE; NECROSIS; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; SELENIUM; SELENIUM COMPOUNDS; TIME FACTORS; TUMOR BURDEN; WEIGHT LOSS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; MUS MUSCULUS; PICHIA JADINII;

EID: 84865067162     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.06.001     Document Type: Article

References (39)

1. Brown K.M., Arthur J.R. Selenium, selenoproteins and human health: a review. Public Health Nutrition 2001, 4:593-599.
2. Rayman M.P. Food-chain selenium and human health: emphasis on intake. Br J Nutr 2008, 100:254-268.
3. Dong Y., Lee S.O., Zhang H.T., Marshall J., Gao A.C., Ip C. Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res 2004, 64:19-22.
4. Jiang C., Wang Z., Ganther H., Lu J.X. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res 2001, 61:3062-3070.
5. Cho S.D., Jiang C., Malewicz B., Dong Y., Young C.Y.F., Kang K.S., et al. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol Cancer Ther 2004, 3:605-611.
6. Dong Y., Zhang H.T., Hawthorn L., Ganther H.E., Ip C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res 2003, 63:52-59.
7. Hu H.B., Jiang C., Li G.X., Lu J.X. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. Carcinogenesis 2005, 26:1374-1381.
8. Jiang C., Wang Z., Ganther H., et al. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol Cancer Ther 2002, 1:1059-1066.
9. Li G.X., Lee H.J., Wang Z., Hu H., Liao J.D., Watts J.C., et al. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 2008, 29:1005-1012.
10. Wang L., Bonorden M.J.L., Li G.X., Lee H.J., Hu H.B., Zhang Y., et al. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prevent Res 2009, 2:484-495.
11. Vogt T.M., Ziegler R.G., Graubard B.I., Swanson C.A., Greenberg R.S., Schoenberg J.B., et al. Serum selenium and risk of prostate cancer in US blacks and whites. Int J Cancer 2003, 103:664-670.
12. Yoshizawa K., Willett W.C., Morris S.J., Stampfer M.J., Spiegelman D., Rimm E.B., et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998, 90:1219-1224.
13. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301:39-51.
14. Duffield-Lillico A.J., Reid M.E., Turnbull B.W., Combs G.F., Slate E.H., Fischbach L.A., et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002, 11:630-639.
15. Fico M.E., Poirier K.A., Watrach A.M., Watrach M.A., Milner J.A. Differential effects of selenium on normal and neoplastic canine mammary cells. Cancer Res 1986, 46:3384-3388.
16. Ip C., Ganther H.E. Activity of methylated forms of selenium in cancer prevention. Cancer Res 1990, 50:1206-1211.
17. Thompson H.J., Meeker L.D., Kokoska S. Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat. Cancer Res 1984, 44:2803-2806.
18. Poirier K.A., Milner J.A. Factors influencing the antitumorigenic properties of selenium in mice. J Nutr 1983, 113:2147-2154.
19. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998, 128:1845-1854.
20. Sunde R.A., Gutzke G.E., Hoekstra W.G. Effect of dietary methionine on the biopotency of selenite and selenomethionine in the rat. J Nutr 1981, 111:76-86.
21. Kennedy J.D., Pierce C.W., Lake J.P. Extrathymic T-cell maturation - phenotypic analysis of T-cell subsets in nude-mice as a function of age. J Immunol 1992, 148:1620-1629.
22. Manning D.D., Reed N.D., Shaffer C.F. Maintenance of skin xenografts of widely divergent phylogenetic origin on congenitally athymic (nude) mice. J Exp Med 1973, 138:488-494.
23. Finley J.W., Davis C.D. Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis. Biofactors 2001, 14:191-196.
24. Lin Y., Boylan L.M., Spallholz J.E. effect of dietary selenium and magnesium on human mammary-tumor growth in athymic nude-mice. Nutr Cancer 1991, 16:239-248.
25. Wu M., Kang M.M., Schoene N.W., Cheng W.H. Selenium compounds activate early barriers of tumorigenesis. J Biol Chem 2010, 285:12055-12062.
26. Davis C.D., Zeng H.W., Finley J.W. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr 2002, 132:307-309.
27. Cheng W.H., Combs G.F., Lei X.G. Knockout of cellular glutathione peroxidase affects selenium-dependent parameters similarly in mice fed adequate and excessive dietary selenium. Biofactors 1998, 7:311-321.
28. Yang Y., Huang F., Ren Y., Xing L., Wu Y., Li Z.S., et al. The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice. Oncology Res 2009, 18:1-8.
29. Lee S.O., Chun J.Y., Nadiminty N., Trump D.L., Ip C., Dong Y., et al. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate 2006, 66:1070-1075.
30. Roy M., Kiremidjianschumacher L., Wishe H.I., Cohen M.W., Stotzky G. Selenium supplementation enhances the expression of interleukin-2 receptor subunits and internalization of interleukin-2. Proc Soc Exp Biol Med 1993, 202:295-301.
31. Roy M., Kiremidjianschumacher L., Wishe H.I., Cohen M.W., Stotzky G. Effect of selenium on the expression of high-affinity interleukin-2 receptors. Proc Soc Exp Biol Med 1992, 200:36-43.
32. Hoffmann P.R., Saux C.J.L., Hoffmann F.W., Chang P.S., Bollt O., He Q.P., et al. A role for dietary selenium and selenoproteins in allergic airway inflammation. J Immunol 2007, 179:3258-3267.
33. Hoffmann F.W., Hashimoto A.C., Shafer L.A., Dow S., Berry M.J., Hoffmann P.R. Dietary selenium modulates activation and differentiation of CD4(+) T cells in mice through a mechanism involving cellular free thiols. J Nutr 2010, 140:1155-1161.
34. Meeker H.C., Eskew M.L., Scheuchenzuber W., Scholz R.W., Zarkower A. Antioxidant effects on cell-mediated-immunity. J Leukocyte Biol 1985, 38:451-458.
35. Shrimali R.K., Irons R.D., Carlson B.A., Sano Y., Gladyshev V.N., Park J.M., et al. Selenoproteins mediate T cell immunity through an antioxidant mechanism. J Biol Chem 2008, 283:20181-20185.
36. Zeng H.W., Combs G.F. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 2008, 19:1-7.
37. Cervi D., Pak B., Venier N.A., Sugar L.M., Nam R.K., Fleshner N.E., et al. Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4. BMC Cancer 2010, 10:258.
38. Li Z., Carrier L., Belame A., Thiyagarajah A., Salvo V.A., Burow M.E., et al. Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis. Breast Cancer Res Treat 2009, 118:33-43.
39. Biswas S., Talukder G., Sharma A. Comparison of clastogenic effects of inorganic selenium salts in mice in vivo as related to concentrations and duration of exposure. Biometals 1999, 12:361-368.